JA

Joseph A. Yanchik Iii

Venture Partner at Apple Tree Partners

Cambridge, Massachusetts

Overview 

Joseph A. Yanchik III is currently a Venture Partner at Apple Tree Partners in Cambridge, Massachusetts, specializing in biotechnology, mergers, and start-ups. With a background that includes roles as Co-Founder, CEO, and Director at Aileron Therapeutics and Co-Founder & CEO at Tokai Pharmaceuticals, Yanchik has a strong track record in strategic planning, drug development, and commercialization within the pharmaceutical industry.

Work Experience 

  • Venture Partner

    2020 - Current

Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.

Raised $5,000,000.00.

  • Co-Founder, CEO & Director

    2005 - 2018

Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.

Raised $256,212,894.00 from Nantahala Capital Management and Bios Partners.

  • Board of Directors

    2005 - 2017

  • Co-Founder & CEO

    2005 - 2008

Tokai Pharmaceuticals specializes in developing and delivering therapies for patients living with cancer.

  • Venture Partner

    2005 - 2009

Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.

Raised $5,000,000.00.

  • Vice President, Corporate Development and Legal Affairs

    2004 - 2005

Mendel Biotechnology is a plant biotechnology company that develops genetic and chemical solutions for a range of agricultural markets.

Raised $20,234,078.00 from CFO Rick, Inc., Capricorn Partners, Monsanto and Ziff Brothers Investments.

  • Chief Financial Officer

    2002 - 2004

  • Attorney

    1997 - 1999

  • Attorney

    1993 - 1997

Articles About Joseph

Relevant Websites